TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,184,708 | +45.1% | 76,581 | +47.3% | 0.09% | +49.2% |
Q2 2023 | $816,496 | +17.0% | 51,973 | +22.7% | 0.06% | +13.0% |
Q1 2023 | $697,994 | +54.8% | 42,354 | +46.5% | 0.05% | +42.1% |
Q4 2022 | $450,887 | +342.0% | 28,903 | +268.1% | 0.04% | +280.0% |
Q3 2022 | $102,000 | -47.2% | 7,853 | -42.8% | 0.01% | -44.4% |
Q2 2022 | $193,000 | -56.5% | 13,721 | -55.7% | 0.02% | -51.4% |
Q1 2022 | $444,000 | +31.4% | 30,985 | +24.8% | 0.04% | +23.3% |
Q4 2021 | $338,000 | -9.6% | 24,832 | +8.8% | 0.03% | -16.7% |
Q3 2021 | $374,000 | +43.8% | 22,824 | +47.5% | 0.04% | +38.5% |
Q2 2021 | $260,000 | -6.1% | 15,474 | +1.9% | 0.03% | -21.2% |
Q1 2021 | $277,000 | +45.8% | 15,182 | +45.2% | 0.03% | +17.9% |
Q4 2020 | $190,000 | +25.0% | 10,459 | +22.5% | 0.03% | +3.7% |
Q3 2020 | $152,000 | +36.9% | 8,536 | +38.3% | 0.03% | +12.5% |
Q2 2020 | $111,000 | +131.2% | 6,174 | +93.9% | 0.02% | +84.6% |
Q1 2020 | $48,000 | +50.0% | 3,184 | +96.2% | 0.01% | +44.4% |
Q4 2019 | $32,000 | – | 1,623 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |